.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Medtronic
Merck
Covington
Novartis
Cipla
US Army
Fuji
Citi

Generated: November 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: acamprosate

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
11995AII6/10/1996MERCK SANTE SASCALCIUM ACAMPROSATE NEW DRUG SUBSTANCE
15819III1/23/2002LIPHA SASHOMOTAURINE (CALCIUM ACAMPROSATE INTERMEDIATE)
21348AII2/20/2008ANGELINI ACRAF SPAACAMPROSATE CALCIUM
21481AII3/24/2008IND SWIFT LABORATORIES LTDACAMPROSATE CALCIUM
21807AII7/14/2008OLON SPAACAMPROSATE CALCIUM
22625AII3/13/2009OLON SPAACAMPROSATE CALCIUM
23973III8/25/2010WUHAN WUYAO PHARMACEUTICAL CO LTDACAMPROSATE CALCIUM, NON-STERILE BULK DRUG SUBSTANCE
25809AII3/30/2012EMCURE PHARMACEUTICALS LTDACAMPROSATE CALCIUM
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Dow
QuintilesIMS
Argus Health
Merck
Chinese Patent Office
McKesson
Cerilliant
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot